Form 4: ClearPoint Neuro Director Acquires Shares as Compensation

Sentiment:

Insider Transaction Report


ClearPoint Neuro, Inc. Director Pascal E. R. Girin acquired 523 shares of common stock at $11.94 per share as part of his director compensation plan.

Summary

  • Director Pascal E. R. Girin acquired 523 shares of ClearPoint Neuro, Inc. common stock.
  • The transaction occurred on July 1, 2025, with shares priced at $11.94 each.
  • These shares were issued as payment for fees owed under the company's Non-Employee Director Compensation Plan, as amended and restated.
  • The issuance was made pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan.
  • Following this transaction, Pascal E. R. Girin beneficially owns 96,634 shares of ClearPoint Neuro, Inc. common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as compensation, generally indicates alignment of interests with shareholders and confidence in the company's future.

Positives

  • Director Pascal E. R. Girin increased his direct beneficial ownership in ClearPoint Neuro, Inc. by acquiring 523 shares.
  • The issuance of shares as compensation aligns the interests of the director with those of shareholders.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

  • Shares were issued in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated.
  • The shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, which is specific to ClearPoint Neuro, Inc. and does not provide broader industry trends or context.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Existing Policy ApplicationShares were issued to the reporting person pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan and the Non-Employee Director Compensation Plan, as amended and restated, demonstrating the application of established corporate governance policies for director compensation.NAReinforces the company's existing compensation framework for non-employee directors, aligning their interests with shareholders through equity awards.

Related Party Transactions

  • Acquisition of 523 common shares by Director Pascal E. R. Girin from ClearPoint Neuro, Inc. as payment for director fees, consistent with the company's Non-Employee Director Compensation Plan.

Stakeholder Impact

  • Shareholders: Increased director ownership may be viewed positively as it aligns the director's financial interests with those of the shareholders.
  • Management/Directors: Pascal E. R. Girin received compensation in the form of company shares, as per the established compensation plan.

Key Dates

DateDescription
06/30/2025Closing price of the issuer's common stock used for the share issuance.
07/01/2025Date of transaction for the acquisition of 523 shares by Director Pascal E. R. Girin.
07/02/2025Date the Form 4 was signed by Power of Attorney.

Keywords

ClearPoint Neuro, CLPT, Form 4, insider transaction, director compensation, stock acquisition, equity, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.